What We’re Watching in the 2018 Legislative Session
As the 2018 General Assembly session begins today, policymakers will be facing decisions that will have significant consequences for working families in Maryland.
As the 2018 General Assembly session begins today, policymakers will be facing decisions that will have significant consequences for working families in Maryland.
Maryland’s 2017 General Assembly Session came to a close Monday night. While there were also plenty of good ideas left on the table, lawmakers took some important steps that will benefit Maryland families and our state’s economy.
Position statement supporting House Bill 631 Given before the Senate Finance Committee There have been several high-profile examples in recent years of drug manufacturers sharply hiking prices for no apparent reason beyond increasing profits. These actions harm Maryland residents –
Position statement supporting House Bill 666 Given before the Senate Finance Committee Skyrocketing costs for prescription drugs are a major factor driving up the costs of health care and insurance for everyone. Providing some basic transparency around those cost increases,
Position statement supporting Senate Bill 415 Given before the Senate Finance Committee There have been several high-profile examples in recent years of drug manufacturers sharply hiking prices for no apparent reason beyond increasing profits. These actions harm Maryland residents –
Position statement supporting Senate Bill 437 Given before the Senate Finance Committee Skyrocketing costs for prescription drugs are a major factor driving up the costs of health care and insurance for everyone. Providing some basic transparency around those cost increases,